Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 11,284,826 entitled, “Methods for Identifying Wave Break During Atrial Fibrillation,” on March 29, 2022 to Mohammad Hassan Shariat and Damian Redfearn. The patent relates to the study methods of intracardiac electrograms during atrial fibrillation which provides clinically significant information that can be used in ablation therapy.

U.S. Patent No. 11,284,826 (PDF, 2.2 MB)